FDA Drug Application (018127) for OVCON-35 by WARNER CHILCOTT

Back to FDA Applications sponsored by WARNER CHILCOTT

Application Number018127
Product Number001
FormTABLET;ORAL-21
Dosage0.035MG;0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameOVCON-35
Active IngredientETHINYL ESTRADIOL; NORETHINDRONE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORETHINDRONE82


Back to FDA Applications sponsored by WARNER CHILCOTT